We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
-12.03%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.32B
AUM Growth
+$267M
(+3.8%)
Cap. Flow
+$1.37B
Cap. Flow
% of AUM
18.68%
Top 10 Holdings %
Top 10 Hldgs %
27.6%
Holding
1,433
New
327
Increased
283
Reduced
238
Closed
555
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$306M |
| 2 |
Cigna
CI
|
+$151M |
| 3 |
Pacira BioSciences
PCRX
|
+$143M |
| 4 |
ENDP
Endo International plc
ENDP
|
+$120M |
| 5 |
Tenet Healthcare
THC
|
+$99.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESPR
Esperion Therapeutics
ESPR
|
+$64.7M |
| 2 |
BCR
CR Bard Inc.
BCR
|
+$62.4M |
| 3 |
Perrigo
PRGO
|
+$52.7M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$49.4M |
| 5 |
SKX
Skechers
SKX
|
+$47.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.8% |
| 2 | Financials | 7.09% |
| 3 | Consumer Discretionary | 5.97% |
| 4 | Energy | 5.17% |
| 5 | Industrials | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
NewMarket
NEU
$7.82B
| $247K | ﹤0.01% |
+691
| New | +$280K |
|
727
Monster Beverage
MNST
$94.3B
| $246K | ﹤0.01% |
10,944
-5,592
| -34% | -$131K |
|
728
Copart
CPRT
$27B
| $244K | ﹤0.01% |
59,264
-122,976
| -67% | -$543K |
|
729
Church & Dwight Co
CHD
$23.4B
| $243K | ﹤0.01% |
5,788
-412
| -7% | -$17.7K |
|
730
Gentex
GNTX
$4.97B
| $243K | ﹤0.01% |
15,688
-2,165
| -12% | -$34.4K |
|
731
LKQ Corp
LKQ
$5.68B
| $243K | ﹤0.01% |
+8,564
| New | +$261K |
|
732
Enviri
NVRI
$623M
| $242K | ﹤0.01% |
+26,679
| New | +$336K |
|
733
Lincoln National
LNC
$8.73B
| $241K | ﹤0.01% |
5,069
+1,668
| +49% | +$89.4K |
|
|
WPXP
734
DELISTED
WPX Energy, Inc.
WPXP
| $241K | ﹤0.01% |
+6,958
| New | +$277K |
|
|
HUB.B
735
DELISTED
HUBBELL INC CL-B
HUB.B
| $241K | ﹤0.01% |
2,833
-62,167
| -96% | -$6.21M |
|
736
Ciena
CIEN
$53.4B
| $238K | ﹤0.01% |
11,499
-23,705
| -67% | -$551K |
|
737
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.12B
| $238K | ﹤0.01% |
+3,607
| New | +$251K |
|
|
HES
738
DELISTED
Hess
HES
| $238K | ﹤0.01% |
4,746
+1,597
| +51% | +$91.4K |
|
|
P
739
DELISTED
Pandora Media Inc
P
| $238K | ﹤0.01% |
11,148
-5,760
| -34% | -$101K |
|
740
Invesco
IVZ
$13.1B
| $237K | ﹤0.01% |
7,600
-15,015
| -66% | -$534K |
|
741
Altria Group
MO
$114B
| $236K | ﹤0.01% |
+4,343
| New | +$233K |
|
742
M&T Bank
MTB
$35.7B
| $236K | ﹤0.01% |
1,935
-909
| -32% | -$114K |
|
|
CLGX
743
DELISTED
Corelogic, Inc.
CLGX
| $235K | ﹤0.01% |
+6,314
| New | +$245K |
|
|
HMHC
744
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $234K | ﹤0.01% |
11,535
-3,857
| -25% | -$92K |
|
745
Johnson & Johnson
JNJ
$618B
| $233K | ﹤0.01% |
2,500
-2,512
| -50% | -$243K |
|
|
PF
746
DELISTED
Pinnacle Foods, Inc.
PF
| $233K | ﹤0.01% |
5,559
-19,849
| -78% | -$897K |
|
747
O'Reilly Automotive
ORLY
$72.9B
| $231K | ﹤0.01% |
13,845
-44,010
| -76% | -$711K |
|
748
East-West Bancorp
EWBC
$17.9B
| $229K | ﹤0.01% |
+5,963
| New | +$252K |
|
|
KERX
749
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $229K | ﹤0.01% |
65,000
+15,000
| +30% | +$100K |
|
|
HOT
750
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $229K | ﹤0.01% |
3,441
-28,363
| -89% | -$2.16M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q3 2015 Portfolio in Review
As of Q3 2015, Visium Asset Management held 1,433 positions worth $7.32B, up 3.8% from $7.05B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management deployed $1.37B of net new capital in Q3 2015, opening 327 new positions and adding to 283 existing holdings. Its largest new stake was Allergan plc: 997,201 shares worth $271M.
By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Perrigo, an estimated $52.7M trimmed.
- Visium Asset Management's largest Q3 2015 buy was Allergan plc: 997,201 shares worth $271M.
- Visium Asset Management added most to Pacira BioSciences in Q3 2015, an estimated $143M increase.
- Visium Asset Management's biggest Q3 2015 reduction was Perrigo, cutting an estimated $52.7M.
- Visium Asset Management fully exited Esperion Therapeutics in Q3 2015, selling an estimated $64.7M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.32B portfolio in Q3 2015.
- Visium Asset Management opened 327 new positions and closed 555 in Q3 2015.
- Visium Asset Management's portfolio value rose 3.8% quarter-over-quarter to $7.32B.
Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.